Search Results - "Denison, U"

Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis by Labidi-Galy, S.I., Rodrigues, M., Sandoval, J.L., Kurtz, J.E., Heitz, F., Mosconi, A.M., Romero, I., Denison, U., Nagao, S., Vergote, I., Parma, G., Nøttrup, T.J., Rouleau, E., Garnier, G., El-Balat, A., Zamagni, C., Martín-Lorente, C., Pujade-Lauraine, E., Fiévet, A., Ray-Coquard, I.L.

“…In the phase III PAOLA-1 study, the addition of maintenance olaparib to bevacizumab in patients with newly diagnosed high-grade ovarian cancer (HGOC) resulted…”
Get full text

Legitimate: Denison U.'s 4th

Get full text

Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO) by Volgger, B.M., Windbichler, G.H., Zeimet, A.G., Graf, A.H., Bogner, G., Angleitner-Boubenizek, L., Rohde, M., Denison, U., Sliutz, G., Fuith, L.C., Fuchs, D., Marth, C.

“…Neopterin is produced by activated macrophages upon stimulation with interferon-γ (IFN-γ) and thus, elevated neopterin concentrations in patients indicate…”
Get full text

Legitimate: Denison U. to Open Tent

Get full text

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial by WINDBICHLER, G. H, HAUSMANINGER, H, STUMMVOLL, W, GRAF, A. H, KAINZ, C, LAHODNY, J, DENISON, U, MÜLLER-HOIZNER, E, MARTH, C

“…Intraperitoneal treatment with interferon-gamma (IFN-gamma) has been shown to achieve surgically documented responses in the second-line therapy of ovarian…”
Get full text

Sylvania woman wins Fulbright scholarship: Denison U. grad to study economic science in Ireland

Get full text

Legitimate: Denison U. Players On Far East Legit Tour

Get full text

Legitimate: Denison U. Strawhat Almost in the Black Before Season Opens

Get full text

123O Randomized phase II trial of neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in early HER2-positive breast cancer (ABCSG-52/ATHENE) by Rinnerthaler, G., Egle, D., Bartsch, R., Schmitt, C.A., Petzer, A.L., Balic, M., Petru, E., Denison, U., Singer, C.F., Bjelic-Radisic, V., Gampenrieder, S.P., Knauer, M., Posch, F., Hlauschek, D., Sölkner, L., Bago-Horvath, Z.A., Filipits, M., Gili, M., Gnant, M.I., Greil, R.

Get full text

36MO Maintenance olaparib plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (OC): 5-year (y) progression-free survival (PFS) by molecular subgroup in the PAOLA-1/ENGOT-ov25 trial by Gonzalez Martin, A.J., Medioni, J., Harter, P., Cropet, C., Cinieri, S., Denison, U., Fujiwara, H., Vergote, I.B., Bologna, A., Hietanen, S., Rodrigues, M.J., Hanker, L.C., Zamagni, C., Hernando Polo, S., Bello Roufai, D., Bauerschlag, D., You, B., Hillemanns, P., Pujade-Lauraine, E., Ray-Coquard, I.L.

Get full text

Development of a nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer based on the CALYPSO trial by Lee, C. K., Guardiola, E., Hogberg, T., Friedlander, M., Bentley, J., Denison, U., Vergote, I. B., Pisano, C., Parma, G., Wimberger, P.

“…Abstract only…”
Get full text

Fallbericht einer Patientin mit Subarachnoidalblutung 5 Minuten post partum by Mossig, M, Denison, U, Neumann, E, Erlacher, W, Sevelda, P

“…Abstract only…”
Get full text

Komplikationsfreie Geburt ohne Folgeschäden nach neoadjuvanter Chemotherapie ab dem 2. Trimenon by Duduleanu, I, Denison, U, Sevelda, P

“…Abstract only…”
Get full text

Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C by OBERMAIR, A, GERAMOU, M, GUCER, F, DENISON, U, GRAF, A. H, KAPSHAMMER, E, NEUNTEUFEL, W, FRECH, I, KAIDER, A, KAINZ, C

“…In several case reports, distension and irrigation of the uterine cavity during fluid hysteroscopy was suspected to cause tumor cell dissemination into the…”
Get full text

Mathematical modeling of CA125 kinetics in recurrent ovarian cancer (ROC) patients treated with chemotherapy and predictive value of early modeled kinetic parameters in CALYPSO trial: A GCIG study by You, B., Colomban, O., Heywood, M., Lee, C., Davy, M., Reed, N., Pignata, S., Fossati, R., Emons, G., Rehman, K. L., Steffensen, K. D., Petru, E., Gebski, V., Burges, A., Tubiana-Matthieu, N., Hansen, M., Vasey, P. A., Denison, U., De Bruyne, P., Oza, A. M.

“…Abstract only…”
Get full text

Cytoprotection of amifostine (A) in ovarian cancer patients receiving paclitaxel/carboplatin (PC) first line chemotherapy in a multicenter phase III trial by Sevelda, P., Sevelda, U., Denison, U., Kaider, A.

“…Abstract only…”
Get full text

Cytoprotection of amifostine (A) in ovarian cancer patients receiving paclitaxel/carboplatin (PC) first line chemotherapy in a multicenter phase III trial by Sevelda, P., Sevelda, U., Denison, U., Kaider, A.

“…Abstract only…”
Get full text

Pain after laparoscopic gynecological surgery and transabdominal or transvaginal hysterectomy: A-872 by Schweitzer, E., Denison, U., Mayrhofer, D., Fitzgerald, R., Schwarz, S.

Get full text

Desensibilisierung nach Hypersensibilisierungreaktion auf Carboplatin zum Erhalt des Therapieansprechens nach Rezidiv eines Zervixkarzinoms by Denison, U, Peters-Engel, C, Schramböck, R, Sattler, G, Mörsen, G, Sevelda, P

“…Abstract only…”
Get full text

Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy by DENISON, Ursula, BAUMANN, Jose, PETERS-ENGL, Christian, SAMONIGG, Hellmut, KRIPPL, Peter, LANG, Alois, OBERMAIR, Andreas, WAGNER, Helga, SEVELDA, Paul

“…Anaemia is frequent in breast cancer patients but often remains undiagnosed and untreated. To determine the incidence of anaemia a prospective survey of…”
Get full text